Subungual melanoma: A retrospective cohort of 157 cases from Brazilian National Cancer Institute

被引:14
作者
Nunes, Luiz Fernando [1 ]
Mendes, Gelcio L. Q. [1 ]
Koifman, Rosalina J. [2 ]
机构
[1] Brazilian Natl Canc Inst, Brazil Connect Bone Tissue Sect, Rio De Janeiro, Brazil
[2] Fundacao Oswaldo Cruz, Dept Epidemiol & Quantitat Methods Hlth, Natl Sch Publ Hlth, Rio De Janeiro, Brazil
关键词
prognosis; subungual melanoma; survival; ACRAL LENTIGINOUS MELANOMA; LYMPH-NODE BIOPSY; CUTANEOUS MELANOMA; SURGICAL-MANAGEMENT; PROGNOSTIC-FACTORS; RECONSTRUCTION; EPIDEMIOLOGY; THICKNESS; DIAGNOSIS; SURVIVAL;
D O I
10.1002/jso.25242
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Subungual melanoma (SM) is rare. The lesions are thick at the time of diagnosis. Few studies have evaluated SM in Brazil. Objective Methods The objective of this study was to investigate the factors associated with the survival of SM patients from the Brazilian National Cancer Institute. One-hundred and fifty-seven patients diagnosed with SM were included in this study. We evaluated the epidemiologic, clinical, and histopathological data. Overall survival (OS) and relapse-free survival (RFS) curves were computed using the Kaplan-Meier method. Multivariable analyses were conducted using the Cox proportional hazard regression model. Results Conclusion Among the 157 patients, 87 (55.4%) were female. The median age was 68 years old. Median tumor depth was 6.0 mm. Lesions were ulcerated in 94 (59.9%). OS and RFS rates for 5 years were 61.0% and 41.8%, respectively. Median follow-up time was 28 months. The factors associated with OS were Breslow thickness and ulceration, and for RFS, they were the anatomical site, Breslow thickness, and ulceration. This is the largest series of SM patients. The 5-year OS and RFS rates were low (61.0% and 48.2%, respectively), and the main prognostic factors for OS were Breslow thickness and ulceration.
引用
收藏
页码:1142 / 1149
页数:8
相关论文
共 35 条
  • [1] Role of Sentinel Lymph Node Biopsy in Patients with Thin Melanoma
    Andtbacka, Robert H. I.
    Gershenwald, Jeffrey E.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (03): : 308 - 317
  • [2] Banfield CC, 1998, BRIT J DERMATOL, V139, P276
  • [3] Prognosis of Acral Melanoma: A Series of 281 Patients
    Bello, Danielle M.
    Chou, Joanne F.
    Panageas, Katherine S.
    Brady, Mary S.
    Coit, Daniel G.
    Carvajal, Richard D.
    Ariyan, Charlotte E.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (11) : 3618 - 3625
  • [4] Boriani F, 2014, EUR REV MED PHARMACO, V18, P1990
  • [5] Bradford PT, 2009, ARCH DERMATOL, V145, P427, DOI 10.1001/archdermatol.2008.609
  • [6] Subungual melanoma: management considerations
    Cohen, Tzeela
    Busam, Klaus J.
    Patel, Ami
    Brady, Mary S.
    [J]. AMERICAN JOURNAL OF SURGERY, 2008, 195 (02) : 244 - 248
  • [7] Staging and Prognosis of Cutaneous Melanoma
    Dickson, Paxton V.
    Gershenwald, Jeffrey E.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 20 (01) : 1 - +
  • [8] Unique prognostic factors in acral lentiginous melanoma
    Egger, Michael E.
    McMasters, Kelly M.
    Callender, Glenda G.
    Quillo, Amy R.
    Martin, Robert C. G., II
    Stromberg, Arnold J.
    Scoggins, Charles R.
    [J]. AMERICAN JOURNAL OF SURGERY, 2012, 204 (06) : 874 - 879
  • [9] FINLEY RK, 1994, SURGERY, V116, P96
  • [10] Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
    Gershenwald, Jeffrey E.
    Scolyer, Richard A.
    Hess, Kenneth R.
    Sondak, Vernon K.
    Long, Georgina V.
    Ross, Merrick I.
    Lazar, Alexander J.
    Faries, Mark B.
    Kirkwood, John M.
    McArthur, Grant A.
    Haydu, Lauren E.
    Eggermont, Alexander M. M.
    Flaherty, Keith T.
    Balch, Charles M.
    Thompson, John F.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) : 472 - 492